Euglucon N is a pharmaceutical drug that belongs to the class of oral antidiabetic medications. It is primarily used for the treatment of diabetes mellitus type 2, a condition characterized by high blood sugar levels resulting from insulin resistance or inadequate insulin production by the pancreas. Euglucon N contains glibenclamide as its active ingredient.
Glibenclamide, also known as glyburide, is a sulfonylurea medication that acts by stimulating the release of insulin from the islet cells in the pancreas. This increase in insulin secretion helps to lower blood glucose levels and promote glucose utilization by the body's tissues.
Euglucon N is typically prescribed for patients with diabetes mellitus type 2 who have not achieved sufficient glycemic control through diet and exercise alone. It is usually taken orally, with or without food, and its dosage is determined based on individual patient requirements and blood sugar levels. Regular monitoring of blood glucose levels is crucial to ensure the medication's effectiveness and prevent potential hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) complications.
Like any medication, Euglucon N may have certain side effects, including hypoglycemia, gastrointestinal disturbances, allergic reactions, and hematological disorders. Hence, it is important to take the drug as prescribed and follow the healthcare professional’s advice.
Overall, Euglucon N is a commonly prescribed medication for managing diabetes mellitus type 2, helping to regulate blood sugar levels and improve glycemic control.
